Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Formulation and Evaluation of Lisinopril Double Layer Tablet

View through CrossRef
Lisinopril is an antihypertensive drug that is primarily used in the treatment of hypertension, congestive heart failure, heart attacks and also in preventing renal and retinal complication of diabetes that acts by inhibiting angiotension converting enzyme (ACE). The present investigation deals with the formulation of lisinopril double layer tablet containing 100 mg fast release layer and 100 mg sustained release layer to be formulated using wet granulation method. Twelve formulations are prepared for bilayered tablets; 6 formulas for fast release layer study (FF1 to FF6) and another 6 formulas for the sustained release layer study. Friability of all formulation was less than 1%, which indicates the tablets had good mechanical resistance. Drug content was found to be uniform in all formulas. The tablet thickness was found to be 5.12 to 5.31 mm. Acceptable weight variation and content uniformity. Hardness was low for fast release lisinopril layer formulas FF1 to FF6, while it was high for formulas used to study the sustained release layer (SF1 to SF6). On the other hand disintegration time was short for formulas containing super disintegrant as crospovidone 15, and 10 seconds, croscarmelose 27, and 24 seconds and sodium starch glycolate 24, and 19 seconds and the shortest time for disintegration was for crospovidone containing formulas (FF1, and FF4); 15, and 10 seconds respectively for fast release layer study with no disintegration for the formulas used to study the sustained release of lisinopril. At the same time the release study for formulas containing crospovidone was within 20 minutes, while formulas containing HPMC K100 was 12 hours release. To be concluded that double layer tablets were attempted to be prepared for controlled drug delivery. The first layer of lisinopril provides the initial drug release while the second layer provides sustained release of lisinopril for increase patient compliance and decrease frequency of dosing for more control of hyper tension.
Title: Formulation and Evaluation of Lisinopril Double Layer Tablet
Description:
Lisinopril is an antihypertensive drug that is primarily used in the treatment of hypertension, congestive heart failure, heart attacks and also in preventing renal and retinal complication of diabetes that acts by inhibiting angiotension converting enzyme (ACE).
The present investigation deals with the formulation of lisinopril double layer tablet containing 100 mg fast release layer and 100 mg sustained release layer to be formulated using wet granulation method.
Twelve formulations are prepared for bilayered tablets; 6 formulas for fast release layer study (FF1 to FF6) and another 6 formulas for the sustained release layer study.
Friability of all formulation was less than 1%, which indicates the tablets had good mechanical resistance.
Drug content was found to be uniform in all formulas.
The tablet thickness was found to be 5.
12 to 5.
31 mm.
Acceptable weight variation and content uniformity.
Hardness was low for fast release lisinopril layer formulas FF1 to FF6, while it was high for formulas used to study the sustained release layer (SF1 to SF6).
On the other hand disintegration time was short for formulas containing super disintegrant as crospovidone 15, and 10 seconds, croscarmelose 27, and 24 seconds and sodium starch glycolate 24, and 19 seconds and the shortest time for disintegration was for crospovidone containing formulas (FF1, and FF4); 15, and 10 seconds respectively for fast release layer study with no disintegration for the formulas used to study the sustained release of lisinopril.
At the same time the release study for formulas containing crospovidone was within 20 minutes, while formulas containing HPMC K100 was 12 hours release.
To be concluded that double layer tablets were attempted to be prepared for controlled drug delivery.
The first layer of lisinopril provides the initial drug release while the second layer provides sustained release of lisinopril for increase patient compliance and decrease frequency of dosing for more control of hyper tension.

Related Results

Lisinopril Improves Aortic Compliance and Renal Flow
Lisinopril Improves Aortic Compliance and Renal Flow
Abstract We compared the systemic and regional hemodynamic effects of nifedipine and lisinopril in 26 elderly hypertensive patients with the use of the pulsed Doppler u...
Enhancement of EPC migration by high-dose lisinopril is superior compared to captopril and ramipril
Enhancement of EPC migration by high-dose lisinopril is superior compared to captopril and ramipril
Background: Angiotensin-converting enzyme (ACE) inhibitors have been shown to promote endothelial progenitor cell (EPC) function. However, the efficacies of dif...
Perbandingan Beberapa Bahan Pengisi pada Formulasi Tablet Hisap
Perbandingan Beberapa Bahan Pengisi pada Formulasi Tablet Hisap
Abstrak. Tablet hisap adalah tablet padat yang mengandung satu atau lebih bahan obat. Biasanya tablet hisap ini memiliki rasa dan aroma yang manis sehingga dapat larut perlahan dal...
Lisinopril Reverses Left Ventricular Hypertrophy Through Improved Aortic Compliance
Lisinopril Reverses Left Ventricular Hypertrophy Through Improved Aortic Compliance
We treated with nifedipine or lisinopril 38 essential hypertensive patients with left ventricular hypertrophy. The study had a single-blind crossover design; nifedipine or lisinopr...
REVIEW ARTIKEL: PENGARUH PENAMBAHAN KONSENTRASI MALTODEXTRIN TERHADAP KARAKTERISTIK FISIK SEDIAAN TABLET
REVIEW ARTIKEL: PENGARUH PENAMBAHAN KONSENTRASI MALTODEXTRIN TERHADAP KARAKTERISTIK FISIK SEDIAAN TABLET
Sediaan Tablet merupakan sediaan paling dikenal sebagai sediaan takaran tunggal yang dikempa cetak sehingga padat dan berbentuk tabung pipih atau sirkuler dengan permukaan rata ata...
Corneal fibrosis therapies and investigations in the canine corna in vitro
Corneal fibrosis therapies and investigations in the canine corna in vitro
PHASE 1: ABSTRACT Purpose: To evaluate the safety and anti-fibrotic effects of the drugs, angiotensin-converting enzyme inhibitor (ACE-I) lisinopril and rho-kinase inhibitor (ROCK-...
Detectability of an intermediate layer by magnetotelluric sounding
Detectability of an intermediate layer by magnetotelluric sounding
Abstract The recent publication by Verma and Mallick (1979) on the detectability of an intermediate layer by time domain EM sounding provides some informative ans...
Experimental Evaluation of Consolidation Behavior of Double-Layer Soft Soil Ground
Experimental Evaluation of Consolidation Behavior of Double-Layer Soft Soil Ground
Abstract Double-layer grounds are characterized by one layer of soft soil on the top of another, which are frequently encountered in land reclamation projects in Chi...

Back to Top